BGI Genomics (SHE:300676) posted third-quarter attributable net loss of 27.2 million yuan, widening 81% from the previous year.
Losses per share deepened 81% to 0.0653 yuan, according to a Friday filing with the Shenzhen bourse.
The genomics services provider's operating revenue climbed 9.2% year over year to 1.04 billion yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments